What does Alpha GPC do?

Choline compound with moderate evidence for supporting cognitive function in older adults and dementia patients.

Most clinical trials are older (1990s), open-label, or lack rigorous placebo controls — results may be less reliable than modern RCT standards

← All Ingredients Cognitive

Alpha GPC

Also known as: Alpha-glycerophosphocholine, L-Alpha-Glycerylphosphorylcholine, Choline Alfoscerate, α-GPC, Choline Alphoscerate

Effective Dosage

400-1200 mg daily based on study doses

What the Science Says

Alpha GPC is a naturally occurring choline compound found in the brain and in foods like egg yolks. It works by delivering choline to the brain, where it helps produce acetylcholine — a neurotransmitter critical for memory and learning. Clinical trials in older adults and patients recovering from stroke or dementia show meaningful improvements in memory, mental clarity, and cognitive test scores, particularly at doses of 400–1200 mg per day over several months.

What It Doesn't Do

Not proven to boost cognition in healthy young adults. No evidence it enhances athletic performance in humans. Won't reverse Alzheimer's disease. Most strong evidence comes from sick or elderly populations — don't assume the same benefits apply to healthy people. Not a substitute for medical treatment of dementia or stroke.

Evidence-Based Benefits

Alpha GPC is a choline compound that is believed to enhance cognitive function, particularly in areas such as memory and learning. Some studies suggest it may improve cognitive performance in older adults and support recovery after stroke.

Moderate Evidence

Effective at: 300-1200 mg daily

Source: PubMed, NIH DSLD

Absorption & Bioavailability

Good — Alpha GPC is well-absorbed orally and crosses the blood-brain barrier efficiently, raising plasma choline levels measurably within weeks of supplementation.

Red Flags to Watch For

Most clinical trials are older (1990s), open-label, or lack rigorous placebo controls — results may be less reliable than modern RCT standards
High doses (2000 mg/kg in animal studies) caused liver enzyme changes and reduced body weight in female rats — human safety at very high doses is not fully established
Lab study found Alpha GPC may increase vulnerability of brain cells (astrocytes) to anesthetic toxicity — potential concern for surgical patients
Many studies were conducted in stroke or dementia patients; benefits in healthy adults are not well-supported by the provided evidence
Widely used in 1000+ registered supplement products, but regulatory approval as a food ingredient is recent (Canada 2023, China 2024) — long-term food-level safety data is still emerging

Research Sources

PubMed
NIH DSLD

This information is for educational purposes only and is not medical advice. Always consult a healthcare professional before starting any supplement regimen. Last updated: 2026-04-06